AMR experts from Industry, SMEs, academia and public bodies discussed the impact of COVID-19 on AMR innovation. Overall, optimism is there that rising public…
Investment climate for companies active in AMR was rather weak for a long time. However, over the past year, situation has slightly improved and…
During the third day of the virtual 5th AMR Conference, the important role of governments and policy makers with regard to bring forward pull…
With INCATE a new public-private consortium was launched on 25 August to boost the development of new drugs and start-ups in the AMR space.…
We spoke with Aleks Engel from the Novo Holdings Repair Impact Fund, one of the speakers at the AMR Conference 2021, about the current…
A group of experts has shown in an analysis that also in high-income countries patient access to new antibacterials is currently very limited. Authors:…
The Global AMR R&D Hub has published a report which highlights the mismatch between global needs and commercial potential of AMR innovation. One of…
CARB-X is organizing a webinar to celebrate its European projects and funding partners which have supported the initiative over the past five years. Antibiotic-resistance…
British clinical trials expert Stephen Senn explains in a viewpoint essay on the GARDP website what can be learnt from COVID-19 vaccine trials for…
